相关实验视频
Updated: Jul 7, 2026

06:09
Adult and Pediatric Porcine Model of Acute Volume Overload
Published on: January 12, 2024
在单一中心的儿科和成人息护理服务之间的服务利用率差异
Iris Fried1,2,3, Adir Shaulov3,4, Shoshana Revel-Vilk2,3
1Pediatric Palliative Care Unit, Wilf Children's Hospital, Shaare Zedek Medical Center, Jerusalem, Israel.
Palliative & supportive care
|October 3, 2024
概括
成人和儿科息护理 (PC) 显著不同. 儿童需要更长时间的PC参与和更多的罕见疾病咨询,与常见慢性疾病的成年人不同. 规划应解决这些独特的需求.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 儿科医疗保健 儿科医疗保健
- 无瘤专业的患者护理
背景情况:
- 目前的息治疗 (PC) 建议缺乏对成人和儿科需求的区分.
- 现有的指导方针没有具体规定儿童和成人PC的人员要求或社区和医院设置之间的护理分配.
- 需要了解非瘤成人和儿科患者医院PC服务的不同利用模式.
研究的目的:
- 评估成人和儿科非瘤患者在使用医院息护理 (PC) 服务方面的差异.
- 确定影响这些不同人群使用PC服务的关键人口和临床因素.
主要方法:
- 对非瘤患者进行了一项回顾性研究,这些患者由成人或儿科PC团队观察.
- 收集的数据包括人口统计,诊断,咨询频率,PC参与的持续时间和后续情况.
- 该研究期为2021年6月至2023年7月,在单一的三级医院进行.
主要成果:
- 445名成人和48名儿童接受了PC服务.
- 成年人通常患有常见的慢性疾病,住院死亡率高.
- 患有罕见疾病的儿童往往较年轻,需要更长的PC随访 (114 vs. 5天) 和更多的咨询 (8.5 vs. 4),住院死亡率较低 (25% vs. 61.6%).
结论:
- 成年PC患者经常出现常见的慢性疾病,由初级保健管理.
- 儿科PC患者经常患有罕见,复杂的限制生命的疾病,需要专门的医院服务.
- 未来的PC规划必须考虑这些差异,倡导加强成人初级保健从业人员的培训,并为儿科患者提供早期的医院PC转诊.
相关概念视频
Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...